Skip to main content
. 2019 Aug 9;42(10):1912–1920. doi: 10.2337/dc19-0415

Table 3.

Categories of gallbladder or biliary disease complications (pooled algorithm-based and non–algorithm-based events)

Category of gallbladder or biliary complication Liraglutide, n = 4,668
Placebo, n = 4,672
Total, n = 9,340
N % E N % E N % E
All events 141 3.02 155 88 1.88 113 229 2.45 268
Uncomplicated gallbladder stones 16 0.34 17 5 0.11 7 21 0.22 24
Complicated gallbladder stones 52 1.11 54 40 0.86 42 92 0.99 96
 Leading to cholecystectomy 31 0.66 32 22 0.47 22 53 0.57 54
Cholecystitis 51 1.09 56 33 0.71 35 84 0.90 91
 Without gallbladder stones 19 0.41 21 8 0.17 8 27 0.29 29
 With gallbladder stones 30 0.64 33 22 0.47 24 52 0.56 57
 Unknown stone status 2 0.04 2 3 0.06 3 5 0.05 5
 Leading to cholecystectomy 39 0.84 43 26 0.56 28 65 0.70 71
Biliary obstruction 25 0.54 28 16 0.34 29 41 0.44 57
 Bile duct stones 22 0.47 24 13 0.28 18 35 0.37 42
 Bile duct stenosis 3 0.06 4 3 0.06 11 6 0.06 15
 Intervention
  ERCP 9 0.19 11 6 0.13 18 15 0.16 29
   Papillotomy 4 0.09 5 6 0.13 10 10 0.11 15
   Stenting (biliary prosthesis) 1 0.02 2 2 0.04 11 3 0.03 13
  Cholecystectomy 12 0.26 13 8 0.17 9 20 0.21 22

Seven events and six patients were excluded, since the seven events were assessed to be unrelated to biliary disease. The seven excluded events occurred in seven patients, but, as one of the patients also had another gallbladder- or biliary tract–related event, this patient was included in the analyses for the other event. For some patients, cholecystectomy was reported for two separate events with the same start date. Therefore, more cholecystectomy events than patients with cholecystectomy are listed for some categories of gallbladder or biliary disease. E, number of events; n, number of patients; N, number of patients with an event; %, percentage of patients.